Jazz Pharmaceuticals
JAZZ
$128.91
Share price
-0.63%
Change (1 day)
-13.63%
Change (1 year)
Categories
Market capitalization of Jazz Pharmaceuticals (JAZZ)
Market cap: $8.25 Billion
As of June 2023 Jazz Pharmaceuticals has a market cap of $8.25 Billion. This makes Jazz Pharmaceuticals the world's 1731th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Jazz Pharmaceuticals from 2007 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $8.25 B | -17.75% |
| 2022 | $10.03 B | 28.09% |
| 2021 | $7.83 B | -15.53% |
| 2020 | $9.27 B | 10.63% |
| 2019 | $8.38 B | 17.57% |
| 2018 | $7.12 B | -11.7% |
| 2017 | $8.07 B | 23.62% |
| 2016 | $6.53 B | -24.22% |
| 2015 | $8.61 B | -13.21% |
| 2014 | $9.92 B | 35.61% |
| 2013 | $7.32 B | 137.02% |
| 2012 | $3.08 B | 89.69% |
| 2011 | $1.62 B | 107.09% |
| 2010 | $0.78 B | 219.3% |
| 2009 | $0.24 B | 419.79% |
| 2008 | $47.38 M | -86.87% |
| 2007 | $0.36 B |
End of Day market cap according to different sources
On Jun 6th, 2023 the market cap of Jazz Pharmaceuticals was reported to be:
$8.25 Billion
$8.25 Billion
$8.25 Billion
$8.25 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $211.24 B | 2,460.22% | 🇨🇭 Switzerland |
 AmerisourceBergen
ABC | $35.25 B | 327.26% | 🇺🇸 USA |
 Endo International
ENDPQ | $10.58 M | -99.87% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | $8.22 B | -0.31% | 🇮🇱 Israel |